Urinary peptide patterns in native kidneys and kidney allografts

Transplantation

Volumn 87, Issue 12, 2009, Pages 1807-1813

  Zhang, Yan ^a   Oetting, William S ^a,d   Harvey, Stephen B ^a   Stone, Matthew D ^a   Monkkonen, Teresa ^a   Matas, Arthur J ^b   Cosio, Fernando G ^c   Nelsestuen, Gary L ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c MAYO CLINIC   (United States)

^d NONE   (United States)

Author keywords

Acute rejection; Biomarkers; Kidney allografts; Protein profiles; Proteomics

Indexed keywords

ALPHA 1 ANTITRYPSIN; BETA 2 MICROGLOBULIN; PREALBUMIN; SPHINGOLIPID ACTIVATOR PROTEIN; SPHINGOLIPID ACTIVATOR PROTEIN B; SYNAPSIN I; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CHILD; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; FEMALE; GRAFT RECIPIENT; HUMAN; KIDNEY ALLOGRAFT; KIDNEY DISEASE; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN URINE LEVEL; SCHOOL CHILD; URINALYSIS;

EID: 67649625458     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181a66595     Document Type: Article

References (25)

1. Gonzalez-Buitrago JM, Ferreira L, Lorenzo I. Urinary proteomics. Clin Chim Acta 2007; 375: 49.
2. Dihazi H, Muller GA. Urinary proteomics: A tool to discover biomarkers of kidney diseases. Expert Rev Proteomics 2007; 4: 39.
3. Theodorescu D, Mischak H. Mass spectrometry based proteomics in urine biomarker discovery. World J Urol 2007; 25: 435.
4. Niwa T. Biomarker discovery for kidney diseases by mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2008; 870: 148.
5. Merchant ML, Klein JB. Proteomics and diabetic nephropathy. Semin Nephrol 2007; 27: 627.
6. Clarke W, Silverman BC, Zhang Z, et al. Characterization of renal allograft rejection by urinary proteomic analysis. Ann Surg 2003; 237: 660.
7. Clarke W. Proteomic research in renal transplantation. Ther Drug Monit 2006; 28: 19.
8. O'Riordan E, Orlova TN, Mei JJ, et al. Bioinformatic analysis of the urine proteome of acute allograft rejection. J Am Soc Nephrol 2004; 15: 3240.
9. Schaub S, Wilkins JA, Antonovici M, et al. Proteomic-based identification of cleaved urinary beta2-microglobulin as a potential marker for acute tubular injury in renal allografts. Am J Transplant 2005; 5: 729.
10. Schaub S, Rush D, Wilkins J, et al. Proteomic-based detection of urine proteins associated with acute renal allograft rejection. J Am Soc Nephrol 2004; 15: 219.
11. Schaub S, Mayr M, Honger G, et al. Detection of subclinical tubular injury after renal transplantation: Comparison of urine protein analysis with allograft histopathology. Transplantation 2007; 84: 104.
12. Oetting WS, Rogers TB, Krick TP, et al. Urinary beta2-microglobulin is associated with acute renal allograft rejection.AmJ Kidney Dis 2006; 47: 898.
13. Wittke S, Haubitz M, Walden M, et al. Detection of acute tubulointerstitial rejection by proteomic analysis of urinary samples in renal transplant recipients. Am J Transplant 2005; 5: 2479.
14. Baggerly KA, Morris JS, Coombes KR. Reproducibility of SELDI-TOF protein patterns in serum: Comparing data sets from different experiments. Bioinformatics 2004; 20: 777.
15. Baggerly KA, Morris JS, Edmonson SR, et al. Signal in noise: Evaluating reported reproducibility of serum proteomic tests for ovarian cancer. J Nat Canc Inst 2005; 97: 307.
16. Petricoin EF III, Ornstein DK, Paweletz CP, et al. Serum proteomic patterns for detection of prostate cancer. J Natl Cancer Inst 2002; 94: 1576.
17. Petricoin EF, Ardekani AM, Hitt BA, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002; 359: 572.
18. Nelsestuen GL, Zhang Y, Martinez MB, et al. Plasma protein profiling: Unique and stable features of individuals. Proteomics 2005; 5: 4012.
19. Faull KF, Whitelegge JP, Higginson J, et al. Cerebroside sulfate activator protein (Saposin B): Chromatographic and electrospray mass spectrometric properties. J Mass Spectrom 1999; 34: 1040.
20. Fluharty AL, Lombardo C, Louis A, et al. Preparation of the cerebroside sulfate activator (CSAct or saposin B) from human urine. Mol Genet Metab 1999; 68: 391.
21. Kasthuri RS, Verneris MR, Ibrahim HN, et al. Studying multiple protein profiles over time to assess biomarker validity. Expert Rev Proteomics 2006; 3: 455.
22. Candiano G, Musante L, Bruschi M, et al. Repetitive fragmentation products of albumin and alpha1-antitrypsin in glomerular diseases associated with nephrotic syndrome. J Am Soc Nephrol 2006; 17: 3139.
23. Nelsestuen GL, Martinez MB, Hertz MI, et al. Proteomic identification of human neutrophil alpha-defensins in chronic lung allograft rejection. Proteomics 2005; 5: 1705.
24. Zhang Y, Wroblewski M, Hertz MI, et al. Analysis of chronic lung transplant rejection by MALDI-TOF profiles of bronchoalveolar lavage fluid. Proteomics 2006; 6: 1001.
25. O'Riordan E, Orlova TN, Podust VN, et al. Characterization of urinary peptide biomarkers of acute rejection in renal allografts. Am J Transplant 2007; 7: 930.